Alterations in rat brain [3H]-TCP binding following chronic phencyclidine administration

Area of Science:

• Neuroscience
• Pharmacology
• Receptor Binding Assays

Background:

• Phencyclidine (PCP) is a dissociative anesthetic with known psychotomimetic effects.
• Chronic PCP exposure is hypothesized to alter neurotransmitter systems, particularly the N-methyl-D-aspartate (NMDA) receptor complex.
• Understanding PCP's long-term effects on its own binding sites is crucial for elucidating its neurobiological impact.

Purpose of the Study:

• To investigate the effects of chronic phencyclidine (PCP) administration on PCP receptor binding in rat brains.
• To quantify changes in the maximum binding capacity (Bmax) and affinity of PCP receptors following sustained PCP exposure.

Main Methods:

• Rats received daily subcutaneous infusions of phencyclidine (PCP) or saline for 10 days via osmotic minipumps.
• Brain homogenates were prepared 24 hours after the final dose.
• Saturation binding studies using [3H]-TCP were performed to assess PCP receptor characteristics.

Main Results:

• Chronic PCP treatment led to a statistically significant increase in the maximum binding capacity (Bmax) for [3H]-TCP.
• A significant decrease in the affinity of PCP receptors for [3H]-TCP was observed in the PCP-treated group compared to saline controls.

Conclusions:

• Chronic phencyclidine (PCP) exposure alters the neurochemical environment of PCP receptors in the rat brain.
• These alterations include an upregulation of receptor number (increased Bmax) and a desensitization (decreased affinity).
• Findings suggest adaptive changes in the NMDA receptor complex in response to prolonged PCP administration.